Table 3 Best corrected visual acuity (BCVA) at the first presentation and at the end of treatment
From: Clinical profile and outcomes of management of orbital cellulitis in Upper Egypt
BCVA | Presenting | Final | P value |
|---|---|---|---|
BCVA | BCVA | ||
(Number = 96) | (Number = 96) | ||
No PL | 12 (12.5%) | 14 (14.6%) | <0.001* |
≤1/60 | 2 (2.1%) | 0 (0%) | |
≤6/60 | 4 (4.2%) | 0 (0%) | |
6/36 | 2 (2.1%) | 0 (0%) | |
6/24 | 4 (4.2%) | 0 (0%) | |
6/18 | 8 (8.3%) | 0 (0%) | |
6/12 | 26 (27.1%) | 8 (8.3%) | |
6/9 | 26 (27.1%) | 32 (33.3%) | |
6/6 | 12 (12.5%) | 42 (43.8%) |